S. Korea to mass-produce antibody treatment of COVID-19 this month | Inquirer News

S. Korea to mass-produce antibody treatment of COVID-19 this month

/ 05:32 PM September 08, 2020
covid-19 antibody


SEOUL — South Korea plans to mass-produce an antibody treatment of the novel coronavirus later this month, health authorities said Tuesday.

The country’s drug ministry is currently reviewing phase 2/3 clinical tests for the antibody-based treatment and aims to mass-produce commercial antibodies for the novel coronavirus in September, according to Kwon Jun-wook, deputy chief at the Central Disease Control Headquarters.


Health researchers are currently analyzing results of the phase 1 trial, which was approved by the drug ministry on July 17. They also earned approval for the phase 1 study of the treatment in Britain on July 29.

For blood plasma-based treatment, health authorities said the drug ministry approved the phase 2 study of its development on Aug. 20, and six medical institutions, including Samsung Medical Center and Asan Medical Center, will verify its effectiveness and safety on COVID-19 patients.


Health authorities added the blood plasma material for the phase 2 trial will begin being produce Tuesday and supply of the substance will be completed in mid-October. (Yonhap)

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Antibody Treatment, Coronavirus, coronavirus outbreak, coronavirus pandemic, COVID-19, South korea
For feedback, complaints, or inquiries, contact us.

© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.